Cited by 71Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and OutcomesPrenatal Substance Exposure Effects

Attention-Deficit/Hyperactivity Disorder and Early-Onset Substance Use Disorders

Wilson, Jeffrey J., Levin, Frances R.·2005·Journal of Child and Adolescent Psychopharmacology

Abstract

In recent years, there has been an increased recognition of the common comorbidity of attention-deficit/ hyperactivity disorder (ADHD) and substance use disorder (SUD) among adolescents and adults. ADHD can be an important factor in the pathogenesis and maintenance of SUD; moreover, retrospective studies suggest that treating ADHD during childhood may prevent the development of SUD. In addition, treatment of ADHD among adults, and possibly adolescents, with SUD can reduce their risk of relapse. Theoretical mechanisms that may explain the relationship between ADHD and SUD are explored in this paper. Current research and recommended clinical practices related to the diagnosis and treatment of ADHD with SUD in adolescents are discussed as well. More research is needed to definitively assess the effectiveness and safety of medications in this population of youths with ADHD and SUD.

Integrity signals

Registry

Crossref · 10.1089/cap.2005.15.751

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wilson, J. J., & Levin, F. R.
Affiliations
New York State Psychiatric Institute (US)
Venue
Journal of Child and Adolescent Psychopharmacology
Published
2005-11
Volume
15
Issue
5
Pages
751-763
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W1965719747
Cited by
71
References
69
Citations by year
2025: 1 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 1 · 2014: 5 · 2013: 4 · 2012: 4
FWCI
5.18
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Child and Adolescent Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Food and Drug Administration
  • U.S. Public Health Service (K02 00465, K2314572)
  • National Institute on Drug Abuse
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
attention deficit hyperactivity disorder, substance use disorders, comorbidities, adolescents, adults, ADHD treatment, relapse prevention, ADHD diagnosis
MeSH terms
Adolescent, Central Nervous System Stimulants, Antisocial Personality Disorder, Attention Deficit Disorder with Hyperactivity, Humans, Risk Factors, Age of Onset, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review